Table 1 Baseline characteristics
From: Sex-related differences in outcome of thoracic aortic surgery
Variables | Overall (n = 455)(%) | Female (n = 146)(%) | Male (n = 309((%) | P Values |
|---|---|---|---|---|
Age, y | 54.6 ± 12.72 | 54.5 ± 12.39 | 54.7 ± 12.90 | 0.843 |
Body surface area, m2 | 1.8 ± 0.17 | 1.6 ± 0.14 | 1.8 ± 0.15 | <0.001 |
Maximum aortic diameter (mm/m2) | 51.1 ± 9.58 | 49.9 ± 9.75 | 51.7 ± 9.45 | 0.055 |
Maximum indexed aortic diameter, mm/m2 | 29.1 ± 6.00 | 30.5 ± 6.34 | 28.5 ± 5.73 | 0.001 |
Marfan´s syndrome (%) | 19(4.2) | 10(6.8) | 9(2.9) | 0.076 |
Hypertension(%) | 153(33.6) | 47(32.2) | 106(34.3) | 0.656 |
Diabetes mellitus(%) | 17(3.7) | 8(5.5) | 9(2.9) | 0.192 |
Dyslipidemia(%) | 25(5.5) | 8(5.5) | 17(5.5) | 1.000 |
Renal insufficiency | 10(2.2) | 2(1.4) | 8(2.6) | 0.513 |
Smoking(%) | 119(26.2) | 2(1.4) | 117(37.9) | <0.001 |
Previous Cardiac Surgery(%) | 41(9.0) | 5(3.4) | 36(11.7) | 0.004 |
Coronary artery disease(%) | 34(7.5) | 5(3.4) | 29(9.4) | 0.023 |
Left ventricular ejection fraction(%) | 0.020 | |||
LVEF > 60% | 222(48.8) | 85(58.2) | 137(44.3) | |
LVEF 40–60% | 215(47.2) | 57(39.1) | 158(51.1) | |
LVEF 20–40% | 18(4.0) | 4(2.7) | 14(4.6) | |
LVEF < 20% | 0(0) | 0(0) | 0(0) | |
NYHA class(%) | 0.868 | |||
I | 11(2.4) | 3(2.1) | 8(2.6) | |
II | 186(40.9) | 59(40.4) | 127(41.1) | |
III | 238(52.3) | 79(54.1) | 159(51.4) | |
IV | 20(4.4) | 5(3.4) | 15(4.9) | |
Aortic valve anatomy (%) | 0.250 | |||
Tricuspid valve | 378(83.1) | 117(80.1) | 261(84.5) | |
Bicuspid valve | 77(16.9) | 29(19.9) | 48(15.5) | |
Aortic stenosis(%) | 189(41.5) | 69(47.3) | 120(38.8) | 0.089 |
Aortic insufficiency(%) | 330(72.5%) | 90(61.6%) | 240(77.7%) | <0.001 |
Aortic valve transvalvular pressure difference | 57.1 ± 45.55 | 72.8 ± 52.62 | 52.1 ± 39.44 | 0.036 |